Effervescent Products Market

Introduction of Innovative Dosage Forms Shaping Market Landscape

Pharmaceutical products are administered by various modes of delivery such as oral, nasal, topical, and injectable. Many studies across the world have found that the most commonly administered product form; tablets, are observed as a complex process for a significant population, due to difficulty in swallowing. The demand for optimization of dosage forms has created a necessity to improve compliance. In Germany, Austria, and Switzerland, effervescent product dosage forms are widespread.

Swallowing has been a major barrier to compliance of tablets and capsules, especially with children and elderly. To overcome this challenge, pharmaceutical companies have developed several alternative user-friendly dosage forms such as effervescent tablet, lozenge, chewable tablet, and orally disintegrating granule amongst others. These formulations not only improve acceptability and convenience, but also provide pharmaceutical companies with product line extension, and increase patient life of their existing products.

Gain More Insights about this Report

Manufacturers Focusing on Products that Ease Patients

Effervescent products can easily incorporate large amounts of Active Pharmaceutical Ingredient (API), and could be consumed as a single dose rather than in multiple dosages (depending on the therapy). Effervescent products can turn any liquid into a functional beverage, which eases patients. Companies are focusing on manufacturing novel drugs with ingredients that have tangible effects on patient’s health and lifestyle.

Developing effervescent products, which are easily transformed into functional beverages also contribute largely to the environment as it minimizes the use of plastics and other products. In addition to this, effervescent products are created with flavors that mask poor tasting vitamins, minerals, and other supplements.

High Sodium Content Limiting the Usage of Effervescent Products

Effervescent products available in the market contain sodium bicarbonate, which help in fizz, bubble, and dissolving in a solution. However, sodium bicarbonate on a long-term basis is deliberated to various health concerns such as high blood pressure, which can increase the risk of cardiovascular diseases such as heart strokes.

According to a report published by American Journal of Clinical Nutrition, it takes nearly half an hour for one salty meal to impair arteries to pump the blood. A group of researchers from NHS conducted a study on the outcomes of high salt level in soluble drugs and concluded that sodium containing formulations of effervescent products, should be prescribed with caution. These are associated with significantly increasing the odds of adverse cardiovascular events comparative to standard formulations of drugs.

Healthcare Industry’s Growth in Asia Pacific to August Well for Market

Healthcare spending in the Asia Pacific region has been growing at a significant pace, worldwide. Though the proportion of global healthcare spending in Asia Pacific and rest of the world segments is low, the growth rates in these regional segments have outpaced various developed economies. Rising healthcare spending has increased the demand for pharmaceutical products in Asia Pacific.

Furthermore, contract manufacturing organizations in these regional segments are important outsourcing partners for pharmaceutical companies that supply to North America and Europe. Growth in the healthcare industry in Asia Pacific and RoW are important growth opportunities for the effervescent products market.

Various multinational companies consider the Asia Pacific region to be a strong backend for manufacturing, owing to low cost of overall operations. In the Asia Pacific region, India is the only country with over 175 US FDA approved manufacturing and R&D units, which make it a major hub for companies to outsource their manufacturing and clinical research activities.

Analyst’s Viewpoint

The analyst has concluded that, companies are focusing towards manufacturing of user-friendly dosage forms such as effervescent tablets, powders, and granules. With the development of these dosage forms, companies can increase their revenue, prolong their product’s lifecycle, and differentiate their products from their competitors. Furthermore, North America is expected to continue to dominate the effervescent products market.

However, significant growth of the effervescent products market is prevalent in the Asia Pacific region, owing to the rapid growth of pharmaceutical market in India and China. Distribution of effervescent products through pharmacy is predominantly the most common channel for distribution of effervescent products. However, e-Commerce is expected to offer substantial growth opportunity for the effervescent products market. Ease of use is a key, but not the only factor driving the growth of the effervescent products market.

Quality and affordability of effervescent products is increasingly gaining prominence. Quality and price remained two of the most significant factors for purchase decision for effervescent products. Consumers have been reported preferring these types of products to alternatives due to the “innovative” nature of the product, which also happens to aid in consumption of effervescent products. Furthermore, rising number of target population, awareness, and changing lifestyle are becoming crucial factors for the growth of the effervescent products market during forecast period.